04:32 PM EDT, 03/31/2025 (MT Newswires) -- Robert I Blum, Director, President & CEO, on March 31, 2025, sold 15,000 shares in Cytokinetics ( CYTK ) for $611,250. Following the Form 4 filing with the SEC, Blum has control over a total of 431,795 common shares of the company, with 427,629 shares held directly and 4,166 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1061983/000112760225010672/xslF345X05/form4.xml